Keywords: zentase, demonstrates, efficacy, epi, study, italian, drugmaker

Zentase demonstrates efficacy in EPI study

Article | 02 July 2007

Print This

Italian drugmaker Eurand NV says that the results from two Phase III studies of Zentase (EUR-1008) indicate that it brings ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in